Refractory Bullous Pemphigoid Improved by Discontinuation of Phenytoin as an CYP3A4 Inducer. [electronic resource]
- Acta dermato-venereologica 04 2020
- adv00108 p. digital
Publication Type: Case Reports; Journal Article
1651-2057
10.2340/00015555-3472 doi
Aged Anti-Inflammatory Agents--therapeutic use Anticonvulsants--therapeutic use Cerebral Palsy--complications Cytochrome P-450 CYP3A Inducers--therapeutic use Drug Substitution Epilepsy--complications Humans Levetiracetam--therapeutic use Male Pemphigoid, Bullous--complications Phenytoin--therapeutic use Prednisolone--antagonists & inhibitors